• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

F-18 FDG 联合 11C-胆碱 PET/CT 诊断肝细胞癌。

F-18 FDG in conjunction with 11C-choline PET/CT in the diagnosis of hepatocellular carcinoma.

机构信息

Southern Medical University, Guangzhou, China.

出版信息

Clin Nucl Med. 2011 Dec;36(12):1092-7. doi: 10.1097/RLU.0b013e3182335df4.

DOI:10.1097/RLU.0b013e3182335df4
PMID:22064078
Abstract

PURPOSE

F-18 fluorodeoxyglucose (F-18 FDG) positron emission tomography (PET)/computed tomography (CT) alone has limited sensitivity for the diagnosis of hepatocellular carcinoma (HCC). We hoped to improve the diagnostic sensitivity by combining F-18 FDG and C-choline PET/CT.

MATERIALS AND METHODS

A total of 76 consecutive patients with HCC were prospectively enrolled. Whole-body F-18 FDG PET/CT scan was performed for all patients. In those patients with negative F-18 FDG scans, a regional C-choline PET/CT scan was also performed.

RESULTS

Positive F-18 FDG scans were noted in 61.1% (48/76) patients with HCC. Increased F-18 FDG uptake correlated with decreased tumor differentiation (P = 0.042). In 28 HCC patients with negative F-18 FDG scans, C-choline scan was positive in 71.4% patients. C-choline scan did not detect any significant difference between well- and moderately differentiated HCC (P = 0.585). Compared with F-18 FDG scan, C-choline scan showed a trend toward an improved detection of well-differentiated HCC (66.7% vs. 35.7%, NS). For detection of moderately differentiated HCC, the sensitivity of C-choline and F-18 FDG PET/CT was similar (85.7% vs. 72.0%, P = 0.648). The dual-tracer modality improved the diagnostic sensitivity of F-18 FDG PET/CT alone from 63.1% to 89.5% (P < 0.001).

CONCLUSIONS

F-18 FDG in conjunction with C-choline increases the sensitivity of PET/CT in detecting HCC.

摘要

目的

氟-18 氟代脱氧葡萄糖(F-18 FDG)正电子发射断层扫描(PET)/计算机断层扫描(CT)单独用于诊断肝细胞癌(HCC)的敏感性有限。我们希望通过结合 F-18 FDG 和 C-胆碱 PET/CT 来提高诊断的敏感性。

材料和方法

共前瞻性纳入 76 例 HCC 连续患者。对所有患者进行全身 F-18 FDG PET/CT 扫描。在那些 F-18 FDG 扫描阴性的患者中,还进行了局部 C-胆碱 PET/CT 扫描。

结果

61.1%(48/76)的 HCC 患者 F-18 FDG 扫描阳性。F-18 FDG 摄取增加与肿瘤分化程度降低相关(P=0.042)。在 28 例 F-18 FDG 扫描阴性的 HCC 患者中,C-胆碱扫描阳性率为 71.4%。C-胆碱扫描在高分化和中分化 HCC 之间未发现显著差异(P=0.585)。与 F-18 FDG 扫描相比,C-胆碱扫描对高分化 HCC 的检测显示出改善的趋势(66.7%比 35.7%,无统计学意义)。对于中分化 HCC 的检测,C-胆碱和 F-18 FDG PET/CT 的敏感性相似(85.7%比 72.0%,P=0.648)。双示踪剂方法使 F-18 FDG PET/CT 单独检测的敏感性从 63.1%提高到 89.5%(P<0.001)。

结论

F-18 FDG 联合 C-胆碱可提高 PET/CT 检测 HCC 的敏感性。

相似文献

1
F-18 FDG in conjunction with 11C-choline PET/CT in the diagnosis of hepatocellular carcinoma.F-18 FDG 联合 11C-胆碱 PET/CT 诊断肝细胞癌。
Clin Nucl Med. 2011 Dec;36(12):1092-7. doi: 10.1097/RLU.0b013e3182335df4.
2
Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.双示踪剂PET/CT成像在转移性肝细胞癌评估中的应用
J Nucl Med. 2007 Jun;48(6):902-9. doi: 10.2967/jnumed.106.036673. Epub 2007 May 15.
3
Diagnostic value of combining ¹¹C-choline and ¹⁸F-FDG PET/CT in hepatocellular carcinoma.¹¹C-胆碱与¹⁸F-FDG PET/CT联合应用在肝细胞癌中的诊断价值
Eur J Nucl Med Mol Imaging. 2016 May;43(5):852-859. doi: 10.1007/s00259-015-3241-0. Epub 2015 Nov 18.
4
Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET.使用11C-胆碱PET检测肝细胞癌:与18F-FDG PET的比较
J Nucl Med. 2008 Aug;49(8):1245-8. doi: 10.2967/jnumed.108.052639. Epub 2008 Jul 16.
5
Diagnosis of Hepatocellular Carcinoma Using C11 Choline PET/CT: Comparison with F18 FDG, ContrastEnhanced MRI and MDCT.使用C11胆碱PET/CT诊断肝细胞癌:与F18 FDG、对比增强MRI和MDCT的比较。
Asian Pac J Cancer Prev. 2016;17(7):3569-73.
6
PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT.使用[(18)F]氟胆碱的肝细胞癌患者的PET/CT:与[(18)F]FDG PET/CT的初步比较
Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1285-9. doi: 10.1007/s00259-006-0164-9. Epub 2006 Jun 27.
7
A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.18F-FDG和11C-醋酸盐PET/CT用于检测原发性和转移性肝细胞癌的前瞻性评估。
J Nucl Med. 2008 Dec;49(12):1912-21. doi: 10.2967/jnumed.108.055087. Epub 2008 Nov 7.
8
Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma.¹⁸F-FDG PET CT作为肝细胞癌患者独立预后指标的作用。
Nucl Med Commun. 2013 Aug;34(8):749-57. doi: 10.1097/MNM.0b013e3283622eef.
9
Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.18F-氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)在肝细胞癌评估及分期中的作用,并与肿瘤大小、甲胎蛋白水平及组织学分级进行比较
Int Surg. 2010 Jan-Mar;95(1):67-75.
10
Combined early dynamic (18)F-FDG PET/CT and conventional whole-body (18)F-FDG PET/CT provide one-stop imaging for detecting hepatocellular carcinoma.联合早期动态(18)F-FDG PET/CT和传统全身(18)F-FDG PET/CT可为检测肝细胞癌提供一站式成像。
Clin Res Hepatol Gastroenterol. 2015 Jun;39(3):324-30. doi: 10.1016/j.clinre.2014.10.010. Epub 2014 Nov 11.

引用本文的文献

1
Dynamic FDG PET/CT imaging: quantitative assessment, advantages and application in the diagnosis of malignant solid tumors.动态氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描成像:定量评估、优势及在恶性实体瘤诊断中的应用
Front Oncol. 2025 Apr 14;15:1539911. doi: 10.3389/fonc.2025.1539911. eCollection 2025.
2
Prognostic and diagnostic value of [F]FDG, C-acetate, and [Ga]Ga-FAPI-04 PET/CT for hepatocellular carcinoma.[F]FDG、C-醋酸盐和[Ga]Ga-FAPI-04 PET/CT对肝细胞癌的预后和诊断价值
Eur Radiol. 2025 Jan 21. doi: 10.1007/s00330-025-11352-3.
3
Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma.
用于肝细胞癌成像的正电子发射断层显像(PET)放射性药物的最新进展
Cancers (Basel). 2023 Mar 25;15(7):1975. doi: 10.3390/cancers15071975.
4
Influence of key histological characteristics on 18F-fluorodeoxyglucose /18F-choline positron emission tomography positivity in hepatocellular carcinoma: A machine learning study.关键组织学特征对肝细胞癌中18F-氟脱氧葡萄糖/18F-胆碱正电子发射断层扫描阳性的影响:一项机器学习研究
Front Med (Lausanne). 2023 Jan 19;10:1087957. doi: 10.3389/fmed.2023.1087957. eCollection 2023.
5
18F-FDG /18F-Choline Dual-Tracer PET Behavior and Tumor Differentiation in HepatoCellular Carcinoma. A Systematic Review.18F-氟代脱氧葡萄糖/18F-胆碱双示踪剂PET在肝细胞癌中的行为及肿瘤分化:一项系统评价
Front Med (Lausanne). 2022 Jul 7;9:924824. doi: 10.3389/fmed.2022.924824. eCollection 2022.
6
Progression of AFP SCORE is a Preoperative Predictive Factor of Microvascular Invasion in Selected Patients Meeting Liver Transplantation Criteria for Hepatocellular Carcinoma.AFP SCORE 进展是符合肝癌肝移植标准的患者发生微血管侵犯的术前预测因素。
Transpl Int. 2022 Mar 23;35:10412. doi: 10.3389/ti.2022.10412. eCollection 2022.
7
Prognostic Value of Metabolic Imaging Data of C-choline PET/CT in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.C-胆碱PET/CT代谢成像数据在肝细胞癌肝切除患者中的预后价值
Cancers (Basel). 2021 Jan 26;13(3):472. doi: 10.3390/cancers13030472.
8
Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects.正电子发射断层扫描在肝细胞癌中的应用:现状与展望。
World J Gastroenterol. 2019 Aug 28;25(32):4682-4695. doi: 10.3748/wjg.v25.i32.4682.
9
Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy.基线和治疗后 18F-氟胆碱 PET/CT 预测局部区域治疗后肝细胞癌的结果。
Dig Dis Sci. 2020 Feb;65(2):647-657. doi: 10.1007/s10620-019-05781-6. Epub 2019 Aug 22.
10
Validation of R-2-[F]Fluoropropionic Acid as a Potential Tracer for PET Imaging of Liver Cancer.R-2-[F]氟丙酸作为肝癌正电子发射断层成像潜在示踪剂的验证。
Mol Imaging Biol. 2019 Dec;21(6):1127-1137. doi: 10.1007/s11307-019-01346-1.